drugset / Trial / NCT00004016

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

NCT00004016

Treatment

Summary

RATIONALE: Interferon gamma may interfere with the growth of cancer cells and may be an effective treatment for melanoma and solid tumors. PURPOSE: Phase I trial to study the effectiveness of interferon gamma in treating patients with recurrent or metastatic melanoma or other solid tumors.

Timeline

Start
1999-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject interferon gamma Protein / enzyme biologic Intrathecal

Indications